The present study aimed to evaluate the acute and subacute toxicity profiles of Erodium guttatum extracts in mice using the methods described in the guidelines of the OECD. In the acute toxicity study, the LD50 value was greater than 2000 mg/kg. The subacute toxicity study of E. guttatum extracts showed no significant changes in body or organ weights. The administration of E. guttatum extracts to mice at a dose of 200 mg/kg led to an increase in white blood cells, platelets and hemoglobin. Moreover, the aqueous extract of E. guttatum only decreased liver aspartate aminotransferase (ASAT) levels at a dose of 200 mg/kg, and creatinine and urea levels did not show any significant alterations compared to the control group. Our results showed that the extracts of E. guttatum caused a slight increase in alanine aminotransferase (ALAT) and triglycerides. The histological study showed that mice treated with E. guttatum extracts experienced some histopathological changes in the liver, particularly with the methanolic extract, and slight changes in the kidneys and pancreas. Regarding the renal profile, no toxicity was observed. These results provide basic information on the toxicological profile of E. guttatum used in traditional medicine.

Erodium guttatum is a medicinal plant used traditionally to fight against some pathologies such as microbial infections. In fact, the aim of the present study was to evaluate the antibacterial and antioxidant activities of E. guttatum extracts in addition to their toxicity. To achieve the objectives of this study, methanol, and aqueous extracts of E. guttatum were prepared. Then, antibacterial activity was evaluated against Escherichia coli ATCC 25922,

Objectives The aim of this work is to evaluate the in vitro antioxidant, hypoglycemic, and antiobesity effects of Euphorbia resinifera extracts and investigate the phenolic constituents and the toxicity of these extracts. Methods Phytochemical screening was performed to detect polyphenols and flavonoids. Antioxidant activity was evaluated by four methods (DPPH, ABTS, H 2 O 2 , and xanthine oxidase inhibition). The hypoglycemic effect was determined by the inhibition of α-amylase and α-glucosidase enzymes in vitro and via a starch tolerance study in normal rats. The antiobesity effect was estimated by in vitro inhibition of lipase. Results Phytochemical screening revealed that the ethanolic extract was rich in polyphenols (99 ± 0.56 mg GEA/g extract) and tannins (55.22 ± 0.17 mg RE/g extract). Moreover, this extract showed higher antioxidant activity in different tests the DPPH assay (IC 50 = 53.81 ± 1.83 µg/mL), ABTS assay (111.4 ± 2.64 mg TE/g extract), H 2 O 2 (IC 50 = 98.15 ± 0.68 µg/mL), and xanthine oxidase (IC 50 = 10.26 ± 0.6 µg/mL). With respect to hypoglycemic effect, the aqueous and ethanolic extracts showed IC 50 values of 119.7 ± 2.15 µg/mL and 102 ± 3.63 µg/mL for α-amylase and 121.4 ± 1.88 and 56.6 ± 1.12 µg/mL for α-glucosidase, respectively, and the extracts lowered blood glucose levels in normal starch-loaded rats. Additionally, lipase inhibition was observed with aqueous (IC 50 = 25.3 ± 1.53 µg/mL) and ethanolic (IC 50 = 13.7 ± 3.03 µg/mL) extracts. Conclusion These findings show the antioxidant, hypoglycemic, and hyperlipidemic effects of E. resinifera extracts, which should be investigated further to validate their medicinal uses and their pharmaceutical applications.

Echinops spinosus, belonging to Asteraceae family, is used in folk medicine as an abortifacient and diuretic and for blood circulation, diabetes, stomach pain, indigestion and spasmolytic problems. The objective of this work is the study of acute toxicity, the content of phenolic compounds (polyphenols, flavonoids and tannins), antioxidant activity (DPPH, ABTS, FRAP, H2O2 and xanthine oxidase) and antidiabetic (α-amylase, α-glucosidase and lipase) in vitro and ex-vivo by studying the starch tolerance test. The phytochemical assay showed that the ethanolic extract is the richest in polyphenols, flavonoids and tannins with 77.01 mg GEA/g extract; 544.33 mg RE/g extract, and 32.20 mg EC/g extract, respectively. The ethanolic extract showed better antioxidant activity compared to the aqueous extract with (IC50=13±0.25 µg/mL; IC50=75.11±0.34 mg TE/g extract; IC50=51.1±1.2 mg AAE/g extract; IC50=28.2±2.87 µg/mL and 16.83 ± 0.72 µg/mL) in DPPH, ABTS, FRAP, H2O2 and xanthine oxidase. Extracts of E. spinosus have shown a remarkable inhibitory effect α-amylase and interesting inhibitory effect of α-glucosidase and lipase. The aqueous and ethanolic extract also lowered blood sugar levels to 0.96 and 0.93g/L, respectively, after 90 minutes in starch-loaded rats. Acute toxicity results indicate that E. spinosus extracts are non-toxic with an LD50 greater than 2 g/kg in female Swiss mice. Therefore, the antioxidant and antidiabetic activity may be at the origin of the bioactive compounds contained in the plant E. spinosus. However, in vivo studies on the mechanism of action are needed against oxidative stress associated with diabetes.

No abstract